AzTrials
AzTrials

Traumatic Brain InjuryNCT05622786

Effect of High-Intensity Gait Training Using a Treadmill on Locomotion Recovery in Traumatic Brain Injury Patients

A study testing HIGT - physical rehab and Low intensity physical therapy in people with Traumatic Brain Injury and Gait Disorders, Neurologic, run by Carilion Clinic at 1 site in United States.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The project will consist of subjects who have suffered Traumatic Brain Injury (TBI) and who are able to ambulate on treadmill with or without a harness system. This will be a 4-week controlled study consisting of two groups of TBI patients, high-intensity intervention group and low-intensity control group. Read more about this study

Who is it for?
Ages 18 to 65 yearsHealthy volunteers can take part
What is being tested?
HIGT - physical rehab and Low intensity physical therapy
Could I receive a placebo?
No, everyone receives an active treatment
How many people
11 participants
Where
1 siteUnited States
Study dates
7 Oct 2022to 15 Jun 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 65 years
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • Medical and treadmill screening clearance to participate in this study
  • Persons with mild, moderate, or severe Traumatic Brain Injury at onset (first time or repeats)
  • 18-65 years old persons who are able to ambulate on treadmill with or without assistive devices and with or without need for bodyweight-support harness system
  • Ability to communicate with investigators to follow protocol instructions and respond appropriately
  • Patients who have decision-making capacity and are able to consent for themselves

Who cannot join

  • Unstable orthopedic conditions, for example, unstable craniectomies or weight-bearing restrictions.
  • Unstable cardiac conditions including, unstable angina, unstable cardiac dysrhythmias, myocardial ischemia or hypertension at rest (systolic BP > 140mm Hg and diastolic BP >90 mm Hg, or if over this range, then a physician must clear patient for participation)
  • Acute systemic infection accompanied by fever, body aches or swollen lymph glands.
  • Hospitalization for acute cardiac, pulmonary or metabolic conditions in the past 3 months.
  • Any other physical or mental restrictions preventing participation in the research protocol.
  • Women who are pregnant are being excluded as this is considered a high risk study. They will be asked via verbal questioning via the following statements, "Are you currently pregnant?" or "Are you planning to become pregnant?".
  • Non-English Speakers

Trial locations and contacts

1 site in 1 country.

United States1 site
  • Institute for Orthopaedics and Neurosciences

    Roanoke, Virginia, 24014

Other trials in United States

About this study

The project will consist of subjects who have suffered Traumatic Brain Injury (TBI) and who are able to ambulate on treadmill with or without a harness system. This will be a 4-week controlled study consisting of two groups of TBI patients, high-intensity intervention group and low-intensity control group. Both groups will receive physical therapy treatment 3 times per week for 1 hour. The intervention group will undergo 30-minute sessions of high-intensity walking on a treadmill with an overhead harness attached for safety. In addition, they will also get up to 30-minutes of low-intensity physical therapy in order to receive 1 hour of treatment time. The control group will undergo only low-intensity physical therapy activities for 1-hour. Low-intensity physical therapy will include strength exercises, stretches, balance, and low-intensity gait training. All participants in both groups will complete these outcome measures on the first day of the study, after 2 weeks of participation, and again at the end of 4 weeks or on their last day before discharge from Carilion's services. Later on, all participants in both groups will be followed up to complete the same set of outcome measures at the end of 1 month since completion of the protocol. This follow up session will take up to 45 minutes to complete.

Read the detailed description

Gait, mobility and cognitive function will be first assessed using seven standardized performance-based outcome measures including both mobility and cognitive measures. All participants in both groups will complete these outcome measures on the first day of the study, after 2 weeks of participation, again at the end of 4 weeks, or on their last day before being discharged from Carilion's services, and 1 month after their 4 week completion.

Participants of the intervention group will undergo physical therapy for 3 days a week for 4 weeks, with each session lasting a total of 60 minutes. They will start with 30 minutes of high-intensity gait training (HIGT) followed by up to 30 minutes of low-intensity therapy. For HIGT, participants will be secured safely on a treadmill with or without an overhead harness and unweighting system for successful gait training. Their resting HR and BP would be noted. Participants would begin with a warmup for 3 minutes by walking at low speeds with intensity of 30-50% of heart rate reserve (HRR). HR would be monitored continuously from here onwards till the conclusion of the protocol. Following the warmup, treadmill walking speed will be initially set at target HR of 85%HRR that was noted from the treadmill test. If the participant did not reach 85% HRR during the treadmill test, treadmill speed would be set by subtracting 0.1 mph (or 0.1 treadmill workload unit) from the speed at which they started showing gait instability or backward drift during the treadmill test. The goal would be to have participants walk at high aerobic intensity with target HR between 60-85%HRR, ideally close to 85%HRR, for 25 minutes. The studies report that the closer the heart rate can be maintained to the 85% target HR, the more beneficial the training.

If a participant is unable to achieve at least 60%HRR in the first few minutes of high-intensity phase, the participant's feeling of physical exertion would also be measured by asking them about a score on the Rates of Perceived Exertion (RPE) scale of 0-10. Here the goal would be to have them maintain an exertion intensity score of 5-8. If needed, participants would be allowed to rest by standing or sitting down. The amount of time spent in high-intensity and rest periods would be recorded. BP will also be recorded at 15-minute and 25-minute timepoints, or during rest breaks. At conclusion of 25 minutes of HIGT, participants will cool down for 2 minutes by walking at 30-50% HRR. Their HR and BP will again be measured at the end of the cool down period. Besides HR and BP, participant's oxygen saturation would also be monitored during this protocol using a pulse oximeter to assess blood oxygen levels. Depending on the remaining time and activity tolerance levels, intervention group participants will then perform up to 30 minutes of low-intensity physical therapy until they have reached a total of 60 minutes for that session. These may consist of low-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance, and other therapeutic activities (such as transfers, bed mobility training, etc.) for functional mobility.

Participants in the control group will receive 60-minute sessions of only low-intensity physical therapy for 3 days a week for 4 weeks. Here, the goal is to have the participants work at a lower intensity with a target HR below 60%HRR. Low-intensity physical therapy could include low-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance, and other therapeutic activities (such as transfers, bed mobility training, etc.). During these sessions, HR and BP would be measured and noted at regular intervals to monitor and note the cardiorespiratory intensity of those activities.

Being tested
HIGT - physical rehab, Low intensity physical therapy
Keywords
High-intensity, Gait training, Traumatic Brain injury, Heart rate, Treadmill
Medical subject headings
Brain Injuries, Traumatic, Gait Disorders, Neurologic

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • HIGT - physical rehabOther

    High Intensity Gait Training using treadmill and overhead harness for fall prevention

  • Low intensity physical therapyOther

    Low Intensity Gait Activities

Study groups in NCT05622786
Study groupRoleWhat they receive
High-Intensity Treadmill Gait Training (HIGT)ExperimentalHigh-intensity walking physical therapy with some low intensity therapy.
Receives: Other: HIGT - physical rehab
Low Intensity Physical TherapyActive comparatorLow-intensity gait activities, exercises (such as lower extremity strength training with or without weights or electrical stimulation, sit to stands from a chair, mat exercises for upper/lower extremities and core strength, etc.), stretches, balance training activities, and other therapeutic activities (such as transfers, bed mobility training, etc.).
Receives: Other: Low intensity physical therapy

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Five Times Sit to Stand Test

    Stand up and sit down as quickly as possible 5 times, keeping your arms folded across your chest.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  2. Six Minute Walk Test (6MWT)

    a sub-maximal exercise test used to assess walking endurance and aerobic capacity. Participants will walk around the perimeter of a set circuit for a total of six minutes.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  3. 10 Meter Walk Test (10mWT)

    Assesses walking speed in meters/second (m/s) over a short distance.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  4. Berg Balance Scale (BBS)

    Used to objectively determine a patient's ability (or inability) to safely balance during a series of predetermined tasks. The minimum value of this assessment is 0, and the maximum is 56. A higher score means a better outcome.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  5. Timed Up and Go (TUG)

    Assesses a person's mobility that requires both static and dynamic balance.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  6. Timed Up and Go (Cognitive)

    Complete a TUG test while counting backward by three from a randomly selected number between 20 and 100.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

  7. Montreal Cognitive Assessment (MoCA)

    A rapid screening instrument for mild cognitive dysfunction. The minimum value of this assessment is 0, and the maximum is 30. A higher score means a better outcome.

    Measured: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted21 Nov 2022
  2. Study start7 Oct 2022
  3. Primary completion15 Jun 2023
  4. Study completion15 Jun 2023

Why it stopped: Low enrollment status

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
11 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05622786
Sponsor's protocol ID
IRB-21-1512
Status last verified
Apr 2024
First submitted
20 Oct 2022
Last updated
19 Apr 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Publications

  • Hornby TG, Reisman DS, Ward IG, Scheets PL, Miller A, Haddad D, Fox EJ, Fritz NE, Hawkins K, Henderson CE, Hendron KL, Holleran CL, Lynskey JE, Walter A; and the Locomotor CPG Appraisal Team. Clinical Practice Guideline to Improve Locomotor Function Following Chronic Stroke, Incomplete Spinal Cord Injury, and Brain Injury. J Neurol Phys Ther. 2020 Jan;44(1):49-100. doi: 10.1097/NPT.0000000000000303.

    PubMed 31834165
  • Moore JL, Nordvik JE, Erichsen A, Rosseland I, Bo E, Hornby TG; FIRST-Oslo Team. Implementation of High-Intensity Stepping Training During Inpatient Stroke Rehabilitation Improves Functional Outcomes. Stroke. 2020 Feb;51(2):563-570. doi: 10.1161/STROKEAHA.119.027450. Epub 2019 Dec 30.

    PubMed 31884902
  • Holleran CL, Rodriguez KS, Echauz A, Leech KA, Hornby TG. Potential contributions of training intensity on locomotor performance in individuals with chronic stroke. J Neurol Phys Ther. 2015 Apr;39(2):95-102. doi: 10.1097/NPT.0000000000000077.

    PubMed 25784587
  • Ada L, Dean CM, Morris ME, Simpson JM, Katrak P. Randomized trial of treadmill walking with body weight support to establish walking in subacute stroke: the MOBILISE trial. Stroke. 2010 Jun;41(6):1237-42. doi: 10.1161/STROKEAHA.109.569483. Epub 2010 Apr 22.

    PubMed 20413741
  • Macko RF, Ivey FM, Forrester LW, Hanley D, Sorkin JD, Katzel LI, Silver KH, Goldberg AP. Treadmill exercise rehabilitation improves ambulatory function and cardiovascular fitness in patients with chronic stroke: a randomized, controlled trial. Stroke. 2005 Oct;36(10):2206-11. doi: 10.1161/01.STR.0000181076.91805.89. Epub 2005 Sep 8.

    PubMed 16151035
  • Holleran CL, Hennessey PW, Leddy AL, Mahtani GB, Brazg G, Schmit BD, Hornby TG. High-Intensity Variable Stepping Training in Patients With Motor Incomplete Spinal Cord Injury: A Case Series. J Neurol Phys Ther. 2018 Apr;42(2):94-101. doi: 10.1097/NPT.0000000000000217.

    PubMed 29547484
  • Ardestani MM, Henderson CE, Salehi SH, Mahtani GB, Schmit BD, Hornby TG. Kinematic and Neuromuscular Adaptations in Incomplete Spinal Cord Injury after High- versus Low-Intensity Locomotor Training. J Neurotrauma. 2019 Jun 15;36(12):2036-2044. doi: 10.1089/neu.2018.5900. Epub 2019 Feb 1.

    PubMed 30362878
  • Gadelha A, Voigtmann C. High Intensity Gait Training in Anoxic Brain Injury: A Case Study. Archives of Physical Medicine and Rehabilitation. DOE: https://doi.org/10.1016/j.apmr.2021.07.596

Questions about this trial

What is this clinical trial studying?

A study testing HIGT - physical rehab and Low intensity physical therapy in people with Traumatic Brain Injury and Gait Disorders, Neurologic, run by Carilion Clinic at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 5 inclusion and 7 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 19 Apr 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Low enrollment status). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Five Times Sit to Stand Test (time frame: Through intervention and follow-up period, up to 8 weeks. This would be administered at the beginning, at the end of 2 weeks, at the end of 4 weeks of interventions, and finally at the end of 4 weeks following end of interventions for follow-up.). The study lists 7 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05622786, which also lists 8 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 19 Apr 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in